Antigen Presentation and Lymphocyte Response in Parkinson's Disease
Trial
N/A
Completed
Feb. 20, 2021
A Efficacy, Safety and Pharmacokinetic Study of XP21279 and Sinemet® in Parkinson's Disease Subjects
Trial
Phase 2
Completed
Feb. 17, 2021
The Effect of Kinesiophobia on Physical Activity, Balance and Falling in Parkinson's Disease Patients
Trial
N/A
Completed
Feb. 17, 2021
Multifocal Neuromodulation in Motor and Cognitive Function of People With Parkinson's Disease
Trial
N/A
Unknown
Feb. 16, 2021
A Clinical Study of KDT-3594 in Patients With Early Parkinson's Disease.
Trial
Phase 2
Completed
Feb. 16, 2021
Study of Factors Associated With the Volumetric and Areal Bone Mineral Density and Bone Strength in Parkinson's Disease
Trial
N/A
Unknown
Feb. 15, 2021
Neural Correlates of Cognition in Parkinson's Disease
Trial
N/A
Completed
Feb. 14, 2021
Cholinergic Mechanisms of Gait Dysfunction in Parkinson's Disease Experiments 1 & 2 - Proj #3
Trial
Phase 2
Completed
Feb. 11, 2021
Perception, Cognition, and Gait in Parkinson's Disease
Trial
N/A
Completed
Feb. 10, 2021
Exploration of the Mechanism of Movement Improvement During RBD in Parkinson's Disease Using NIRS
Trial
N/A
Completed
Feb. 8, 2021
Cognitive Dysfunction in Parkinson's Disease
Trial
N/A
Completed
Feb. 8, 2021
Evaluation of a Multimodal Neuroimaging Method for Diagnosis in Parkinsonian Syndromes
Trial
N/A
Completed
Feb. 8, 2021
LRRK2 Activity and Markers of Parkinson's Disease in G2385R Carriers
Trial
N/A
Completed
Feb. 8, 2021
Figure-of-Eight Walk Test in Parkinson
Trial
N/A
Unknown
Feb. 3, 2021
Neurophysiological Characteristics of Subthalamic Deep-brain Stimulation (STN-DBS)
Trial
N/A
Withdrawn
Feb. 2, 2021
Acupuncture for Anxiety in Parkinson's Disease
Trial
N/A
Unknown
Feb. 1, 2021
Follow Up Safety Study of SCH 420814 in Subjects With Parkinson's Disease (P05175)
Trial
Phase 2
Completed
Feb. 1, 2021
Utilization of Target Ranges to Treat Persons With Parkinson's Disease by Objective Measurement Using the PKG
Trial
N/A
Withdrawn
Jan. 31, 2021
Microbiota Modification for the Treatment of Motor Complication of Parkinson´s Disease
Trial
Phase 1
Completed
Jan. 28, 2021